1. Determination of the median effective dose of propofol in combination with different doses of ketamine during gastro-duodenoscopy in children: a randomised controlled trial
- Author
-
Hossam El-Beheiry, Y. Finkelstein, Clyde Matava, S. Jarvis, Jason Hayes, and Carolyne Pehora
- Subjects
Male ,Adolescent ,Sedation ,Vision Disorders ,Endoscopy, Gastrointestinal ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,Double-Blind Method ,Randomized controlled trial ,030202 anesthesiology ,law ,Gastroscopy ,Intubation, Intratracheal ,medicine ,Humans ,Arterial Pressure ,Ketamine ,General anaesthesia ,Child ,Adverse effect ,Duodenoscopy ,Propofol ,Anesthetics, Dissociative ,Dose-Response Relationship, Drug ,business.industry ,Nausea ,030208 emergency & critical care medicine ,Airway obstruction ,medicine.disease ,Clinical trial ,Anesthesiology and Pain Medicine ,Anesthesia ,Anesthesia Recovery Period ,Female ,medicine.symptom ,business ,Anesthetics, Intravenous ,medicine.drug - Abstract
Background Propofol is used to induce deep sedation or general anaesthesia for procedures in children. Adjuvants, such as ketamine, are routinely added to reduce the dose of propofol required and propofol-related adverse events. We conducted a randomised controlled trial to determine the effective bolus dose of propofol in combination with ketamine that induces adequate depth of anaesthesia in 50% of children (ED50) undergoing gastro-duodenoscopy. Methods Children were randomised to one of four doses of ketamine: 0 (control), 0.25, 0.5, and 1 mg kg−1, followed by a dose of propofol according to Dixon's up-and-down methodology. Excessive movement, coughing, gagging, or airway obstruction that prevented endoscope insertion was considered a failure. Results The ED50 of propofol (median, 95% CI) was greater in the ketamine 0, 0.25, and 0.5 mg kg−1 groups compared with the ketamine 1 mg kg−1 group (6.1, 4.1–8.1; 4.5, 2.9–6; 4.7, 3.1–6.2 mg kg−1 vs 1.1, 0.5–1.8 mg kg−1, respectively, P Conclusions Ketamine at 0.5–1 mg kg–1 reduces the dose of propofol required to provide general anaesthesia for gastro-duodenoscopy in children and may reduce the incidence of propofol-related changes in haemodynamics. Clinical trial registration NCT 02295553.
- Published
- 2018
- Full Text
- View/download PDF